Oil-in-water emulsion MF59 increases germinal center B cell differentiation and persistence in response to vaccination

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1617-1627

  Lofano, Giuseppe ^a,b,c   Mancini, Francesca ^a   Salvatore, Giulia ^a   Cantisani, Rocco ^a   Monaci, Elisabetta ^a   Carrisi, Corrado ^a   Tavarini, Simona ^a   Sammicheli, Chiara ^a   Paccani, Silvia Rossi ^a   Soldaini, Elisabetta ^a   Laera, Donatello ^a   Finco, Oretta ^a   Nuti, Sandra ^a   Rappuoli, Rino ^a   De Gregorio, Ennio ^a   Bagnoli, Fabio ^a   Bertholet, Sylvie ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADJUVANT; B7 ANTIGEN; BACTERIAL ANTIGEN; CD38 ANTIGEN; GLYCOL SALICYLATE; HLA ANTIGEN; MIFAMURTIDE; WATER OIL CREAM; BACTERIAL TOXIN; BACTERIUM ANTIBODY; HEMOLYSIN; IMMUNOLOGICAL ADJUVANT; LEUKOCYTE ANTIGEN; MF59 OIL EMULSION; POLYSORBATE; SQUALENE; STAPHYLOCOCCAL ALPHA-TOXIN; STAPHYLOCOCCUS VACCINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL ASSAY; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; EMULSION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GERMINAL CENTER; HELPER CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VACCINATION; ANIMAL; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHENOTYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; B-LYMPHOCYTES; BACTERIAL TOXINS; CELL DIFFERENTIATION; CHEMOTAXIS, LEUKOCYTE; FEMALE; GERMINAL CENTER; HEMOLYSIN PROTEINS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; PHENOTYPE; POLYSORBATES; SQUALENE; STAPHYLOCOCCAL VACCINES; VACCINATION;

EID: 84938945365     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402604     Document Type: Article

References (47)

1. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314: 1936-1938.
2. Clements, C. J., and E. Griffiths. 2002. The global impact of vaccines containing aluminum adjuvants. Vaccine 20(Suppl. 3): S24-S33.
3. Durando, P., G. Icardi, and F. Ansaldi. 2010. MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk. Expert Opin. Biol. Ther. 10: 639-651.
4. O'Hagan, D. T., G. S. Ott, G. V. Nest, R. Rappuoli, and G. D. Giudice. 2013. The history of MF59(-) adjuvant: a phoenix that arose from the ashes. Expert Rev. Vaccines 12: 13-30.
5. Vesikari, T., N. Groth, A. Karvonen, A. Borkowski, and M. Pellegrini. 2009. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. Vaccine 27: 6291-6295.
6. Hem, S. L., and H. Hogenesch. 2007. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev. Vaccines 6: 685-698.
7. Hutchison, S., R. A. Benson, V. B. Gibson, A. H. Pollock, P. Garside, and J. M. Brewer. 2012. Antigen depot is not required for alum adjuvanticity. FASEB J. 26: 1272-1279.
8. Dupuis, M., D. M. McDonald, and G. Ott. 1999. Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Vaccine 18: 434-439.
9. Flach, T. L., G. Ng, A. Hari, M. D. Desrosiers, P. Zhang, S. M. Ward, M. E. Seamone, A. Vilaysane, A. D. Mucsi, Y. Fong, et al. 2011. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17: 479-487.
10. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9: 847-856.
11. De Gregorio, E., E. Caproni, and J. B. Ulmer. 2013. Vaccine adjuvants: mode of action. Front. Immunol. 4: 214.
12. Mosca, F., E. Tritto, A. Muzzi, E. Monaci, F. Bagnoli, C. Iavarone, D. O'Hagan, R. Rappuoli, and E. De Gregorio. 2008. Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl. Acad. Sci. USA 105: 10501-10506.
13. Dupuis, M., K. Denis-Mize, A. LaBarbara, W. Peters, I. F. Charo, D. M. McDonald, and G. Ott. 2001. Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis. Eur. J. Immunol. 31: 2910-2918.
14. Vono, M., M. Taccone, P. Caccin, M. Gallotta, G. Donvito, S. Falzoni, E. Palmieri, M. Pallaoro, R. Rappuoli, F. Di Virgilio, et al. 2013. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. Proc. Natl. Acad. Sci. USA 110: 21095-21100.
15. Calabro, S., M. Tortoli, B. C. Baudner, A. Pacitto, M. Cortese, D. T. O'Hagan, E. De Gregorio, A. Seubert, and A. Wack. 2011. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29: 1812-1823.
16. Ott, G., G. L. Barchfeld, D. Chernoff, R. Radhakrishnan, P. van Hoogevest, and G. Van Nest. 1995. MF59 design and evaluation of a safe and potent adjuvant for human vaccines. In Vaccine Design, Pharmaceutical Biotechnology, Vol. 1995.
17. M. F. Powell and M. J. Newman, eds. Plenum Press, New York, p. 277-296.
18. Galli, G., D. Medini, E. Borgogni, L. Zedda, M. Bardelli, C. Malzone, S. Nuti, S. Tavarini, C. Sammicheli, A. K. Hilbert, et al. 2009. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc. Natl. Acad. Sci. USA 106: 3877-3882.
19. Spensieri, F., E. Borgogni, L. Zedda, M. Bardelli, F. Buricchi, G. Volpini, E. Fragapane, S. Tavarini, O. Finco, R. Rappuoli, et al. 2013. Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses. Proc. Natl. Acad. Sci. USA 110: 14330-14335.
20. Khurana, S., W. Chearwae, F. Castellino, J. Manischewitz, L. R. King, A. Honorkiewicz, M. T. Rock, K. M. Edwards, G. Del Giudice, R. Rappuoli, and H. Golding. 2010. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci. Transl. Med. 2: 15ra5.
21. Khurana, S., N. Verma, J. W. Yewdell, A. K. Hilbert, F. Castellino, M. Lattanzi, G. Del Giudice, R. Rappuoli, and H. Golding. 2011. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci. Transl. Med. 3: 85ra48.
22. Galli, G., K. Hancock, K. Hoschler, J. DeVos, M. Praus, M. Bardelli, C. Malzone, F. Castellino, C. Gentile, T. McNally, et al. 2009. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc. Natl. Acad. Sci. USA 106: 7962-7967.
23. Bubeck Wardenburg, J., and O. Schneewind. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205: 287-294.
24. Rauch, S., A. C. DeDent, H. K. Kim, J. Bubeck Wardenburg, D. M. Missiakas, and O. Schneewind. 2012. Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect. Immun. 80: 3721-3732.
25. Fritz, S. A., K. M. Tiemann, P. G. Hogan, E. K. Epplin, M. Rodriguez, D. N. Al-Zubeidi, J. Bubeck Wardenburg, and D. A. Hunstad. 2013. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin. Infect. Dis. 56: 1554-1561.
26. Ragle, B. E., and J. Bubeck Wardenburg. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77: 2712-2718.
27. Pape, K. A., J. J. Taylor, R. W. Maul, P. J. Gearhart, and M. K. Jenkins. 2011. Different B cell populations mediate early and late memory during an endogenous immune response. Science 331: 1203-1207.
28. Good-Jacobson, K. L., E. Song, S. Anderson, A. H. Sharpe, and M. J. Shlomchik. 2012. CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. J. Immunol. 188: 4217-4225.
29. Anderson, S. M., M. M. Tomayko, A. Ahuja, A. M. Haberman, and M. J. Shlomchik. 2007. New markers for murine memory B cells that define mutated and unmutated subsets. J. Exp. Med. 204: 2103-2114.
30. Schena, F., S. Volpi, C. E. Faliti, F. Penco, S. Santi, M. Proietti, U. Schenk, G. Damonte, A. Salis, M. Bellotti, et al. 2013. Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. Cell Reports 3: 1824-1831.
31. Tomayko, M. M., N. C. Steinel, S. M. Anderson, and M. J. Shlomchik. 2010. Cutting edge: hierarchy of maturity of murine memory B cell subsets. J. Immunol. 185: 7146-7150.
32. Bergmann, B., O. Grimsholm, K. Thorarinsdottir, W. Ren, P. Jirholt, I. Gjertsson, and I.-L. Martensson. 2013. Memory B cells in mouse models. Scand. J. Immunol. 78: 149-156.
33. Dogan, I., B. Bertocci, V. Vilmont, F. Delbos, J. Mégret, S. Storck, C.-A. Reynaud, and J.-C. Weill. 2009. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 10: 1292-1299.
34. Taylor, J. J., K. A. Pape, and M. K. Jenkins. 2012. A germinal centerindependent pathway generates unswitched memory B cells early in the primary response. J. Exp. Med. 209: 597-606.
35. Khurana, S., E. M. Coyle, M. Dimitrova, F. Castellino, K. Nicholson, G. Del Giudice, and H. Golding. 2014. Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization. PLoS One 9: e95496.
36. Kool, M., T. Soullié, M. van Nimwegen, M. A. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882.
37. Seubert, A., E. Monaci, M. Pizza, D. T. O'Hagan, and A. Wack. 2008. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J. Immunol. 180: 5402-5412.
38. Qu, C., E. W. Edwards, F. Tacke, V. Angeli, J. Llodrá, G. Sanchez-Schmitz, A. Garin, N. S. Haque, W. Peters, N. van Rooijen, et al. 2004. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 200: 1231-1241.
39. Langlet, C., S. Tamoutounour, S. Henri, H. Luche, L. Ardouin, C. Grégoire, B. Malissen, and M. Guilliams. 2012. CD64 expression distinguishes monocytederived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 188: 1751-1760.
40. Chakarov, S., and N. Fazilleau. 2014. Monocyte-derived dendritic cells promote T follicular helper cell differentiation. EMBO Mol. Med. 6: 590-603.
41. Du, J., Z. Wu, S. Ren, Y. Wei, M. Gao, G. J. Randolph, and C. Qu. 2010. TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity. Vaccine 28: 6273-6281.
42. Cheong, C., I. Matos, J.-H. Choi, D. B. Dandamudi, E. Shrestha, M. P. Longhi, K. L. Jeffrey, R. M. Anthony, C. Kluger, G. Nchinda, et al. 2010. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143: 416-429.
43. Baumjohann, D., S. Preite, A. Reboldi, F. Ronchi, K. M. Ansel, A. Lanzavecchia, and F. Sallusto. 2013. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 38: 596-605.
44. Rookhuizen, D. C., and A. L. DeFranco. 2014. Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses. Proc. Natl. Acad. Sci. USA 111: E3224-E3233.
45. Gavillet, B. M., C. S. Eberhardt, F. Auderset, F. Castellina, A. Seubert, J. S. Tregoning, P.-H. Lambert, E. De Gregorio, G. Del Giudice, and C.-A. Siegrist. 2015. MF59 mediates its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life. J. Immunol. 194: 4836-4845.
46. Moody, M. A., N. L. Yates, J. D. Amos, M. S. Drinker, J. A. Eudailey, T. C. Gurley, D. J. Marshall, J. F. Whitesides, X. Chen, A. Foulger, et al. 2012. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. J. Virol. 86: 7496-7507.
47. Haynes, B. F., G. Kelsoe, S. C. Harrison, and T. B. Kepler. 2012. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat. Biotechnol. 30: 423-433.